Feasibility of hepatitis C virus testing and linkage in community supervision offices: Great potential but persistent challenges

• Published in: The International journal of drug policy Vol. 103; p. 103668
• Main Authors: Jacka, Brendan P, Bazerman, Laurie B, Dickerson, Collin, Moody, Marc, Martin, Johanna, Patry, Emily, Cady, Treniece, Compere, Hacheming, Boudreau, Matthew, Beckwith, Curt G
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.05.2022; Elsevier Science Ltd
• Subjects: Antibodies; Care cascade; Community; Cure; Diagnostic tests; Drug policy; Feasibility; Feasibility Studies; HCV elimination; healthcare access; Hepacivirus; Hepatitis; Hepatitis C; Hepatitis C - diagnosis; Hepatitis C - epidemiology; Hepatitis C Antibodies; Humans; Intervention; Justice; Laboratories; Mass Screening - methods; Medical diagnosis; Medical screening; Supervision; Care cascade; healthcare access; HCV elimination
• ISSN: 0955-3959; 1873-4758
• DOI: 10.1016/j.drugpo.2022.103668

Persons involved with the justice system have an elevated risk of hepatitis C virus (HCV) yet remain marginalized from treatment. Efforts to eliminate HCV will require targeted interventions within the justice system effective at providing diagnosis and treatment. We implemented a novel HCV screening and treatment intervention for persons under community supervision in Rhode Island, USA during April 2018––March 2020. Participants received rapid point-of-care HCV antibody testing onsite and referral to community laboratory and treatment services as indicated. We assessed the HCV care cascade to identify areas for improvement. Overall, 483 individuals were screened for HCV antibody; 85 (18%) were positive. A minority of participants with positive HCV antibody tests (n=25/85, 29%) presented to community laboratories for confirmatory testing. Among participants that received HCV viral load results and linked to a treatment provider (n=12), four initiated treatment, three had record of completing treatment, and two were confirmed to have achieved cure. Linkage to HCV viral load testing and treatment was challenging in this community supervision population, with substantial loss to follow-up at each step of the HCV cascade. Community supervision remains an important venue for case identification but substantial barriers to accessing HCV treatment exist. Innovative HCV diagnosis and treatment strategies are needed for community supervision populations.